In particular, Konagurthu says, AI/ML can help sift through a field of drug candidates in which the percentage that are ...
To meet rising demand, developers of precision radiopharmaceutical therapies must overcome challenges in global isotope ...
In September 2025, the European Commission (EC), together with the Heads of Medicines Agencies (HMA) and the European ...
SMA is a rare, genetic neuromuscular condition that affects people across age groups. With treatment landscapes evolving ...
Learn how a custom ADA assay was designed, incorporating acid dissociation with the ACE method to overcome drug interference using other standardized formats.
Having a robust immunogenicity assay for accurate evaluation of ADA in animal models is important for enabling effective decision-making during development. Learn how a robust anti-drug antibody assay ...
Darrin Lang is CEO, LABUR. Larry Egan is Vice President of Strategic Technologies, Alnylam Pharmaceuticals Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback